ABBV -- USA Stock USD 107.15 1.88 1.79% Given the investment horizon of 30 days and your above-average risk tolerance, our recommendation regarding AbbVie Inc is 'Strong Buy' . New. This move outpaced the S&P 500's daily ⦠Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $103.95 to a high of $105.20. abbv $105.15 -$2.00 -1.9% Price as of January 4, 2021, 4:12 p.m. EST View Interactive ABBV Charts Payout Estimate. Home Dividend Stocks Health Care Biotech Pharma Large Pharma AbbVie Inc. (ABBV ⦠To see all exchange delays and terms of use please see disclaimer. Cookie Notice. The average analyst price target of ABBV is … There are currently no items in this Watchlist. Wirecard extends gains after big surge to start the year, European stocks and the euro rise after Georgia Senate races, Warnock projected to win Georgia Senate race, as Ossoff clings to slim lead, Stock-market futures mixed, bond yields pop as Democrats win at least one Georgia Senate runoff race, Warnock defeats Loeffler in Georgia Senate runoff, AP projects, Trump remains insistent that Pence has the power to decertify election results. Something went wrong while loading Watchlist. The stock ⦠View AbbVie Inc. ABBV investment & stock information. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. ABBV gets to $125+ this year. The chart below shows how a company's share price and consensus price target have changed over time. Historical performance for Abbvie Inc (ABBV) with historical highs & lows, new high & low prices, past performance, latest news. Real time AbbVie (ABBV) stock price quote, stock graph, news & analysis. Piper Sandler analyst C. Raymond now expects that the company will post earnings of $2.87 per share for the quarter, up from their prior estimate of $2.85. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock… How to buy Abbvie stock on Stash. Yesterday, the shares gained 1.2%, which took the trading range above the 3 ⦠Today, you can download 7 Best Stocks for the Next 30 Days. View our full suite of financial calendars and market data tables, all for free. Click to get this free report AbbVie Inc. (ABBV) : Free Stock Analysis Report To read this article on Zacks.com click here. They called the 2020 crash 45 days early. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. ⦠Move your mouse over past months for details. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. Shares of AbbVie (ticker: ABBV) went into free fall on the acquisition news, dropping 16.3% by the end of the day. © American Consumer News, LLC dba MarketBeat® 2010-2021. The lighter blue line represents the stock's consensus price target. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. This browser is no longer supported at MarketWatch. Identify stocks that meet your criteria using seven unique stock screeners. AbbVie (ABBV) Dividend Stock Analysis. S&P. Learn more. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell. AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. The latest stock analyst recommendation is BUY. Stock Advisor Flagship service. In midday trading on Dec. 11, AbbVie stock was 4.8% above that entry. Export data to Excel for your own analysis. By using this site you agree to the
Each stock's consensus analyst rating is derived from its calculated … 0 strong buy ratings; 12 buy ratings; 3 hold ratings; 2 sell ratings; Ratings as of. Intraday Data provided by FACTSET and subject to terms of use. ABBV updated stock price target summary. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Among these funds, Orbis Investment Management held the most valuable stake in AbbVie Inc (NYSE:ABBV), which was worth ⦠It is a trending stock that is worth watching. AbbVie Inc (Symbol: ABBV) has been named to the Dividend Channel ''S.A.F.E. Receive a free world-class investing education from MarketBeat. 7/12/2019. In a note out Thursday morning, analysts at Citi Research upgraded AbbVie (ticker: ABBV) to Buy from Neutral and set a price target of $90. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%.
", Watch this leaked video before it's removed. 577%. Lightning fast & can cost as Little as 5¢ or even 1¢... Start Your Risk-Free Trial Subscription Here, 3 Reliable Dividend Stocks to Buy in January, It Is Almost Time To Buy More Chewy.com (NYSE:CHWY), FAT Brands (NASDAQ: FAT) Stock is a Compelling Bargain Buy, Former head of China state asset firm sentenced to death, Harley Davidson (NYSE: HOG) Stock Giving Pullback Entries Here, NYSE withdraws plans to delist 3 Chinese phone carriers, South Korean tanker was boarded by armed Iran Guard forces, Simply Good Foods (NYSE:SMPL) Is a Simple Bet On Resolutions, Forward Air Stock: A Lesser-Known Way to Play the Transportation Rebound. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Subscriber Agreement & Terms of Use,
Copyright © 2021 MarketWatch, Inc. All rights reserved. Get the latest broker recommendations from Zacks Investment Research. ABBV stock RSI chart AbbVie stock price history. If you’ve got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead…document.write('
'); Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. Return. During the day the stock fluctuated 2.32% from a day low at $104.85 to a day high of $107.28. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Abbvie stock rose 1% a day after the announcement and is up almost 6% over the past week. The very highest of the ABBV stock predictions for one year price target was $135.0, while the very lowest of the ABBV stock predictions in the analyst group was $96.0 (with a standard deviation of $11.505). AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. All analysis relies on publicly available financial information. NYSE: ABBV Stock price, November 24, (Source: Simply Wall St ) Abbvie, which was spun-off from Abbott Laboratories ( NYSE: ABT ) back in 2013, develops and markets products that are used for treating rheumatology, gastroenterology, oncology, and neurological disorders, such as Parkinsonâs disease. Is AbbVie Inc. worth watching? ABBV: AbbVie Inc. broker recommendations. Dow Jones, a News Corp company. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. AbbVie Inc. (NYSE:ABBV) â Equities researchers at Piper Sandler increased their Q1 2021 EPS estimates for AbbVie in a report issued on Monday, December 14th. Companies in the sub-industry of "pharmaceuticals" are considered alternatives and competitors to AbbVie, including Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), and Zoetis (ZTS). Want the latest recommendations from Zacks Investment Research? Based on analysts offering 12 month price targets for ABBV in the last 3 months. Want to see which stocks are moving? The current consensus among 21 polled investment analysts is to buy stock in AbbVie. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. Today it was reported that the Senior Vice-President Operations of AbbVie (ABBV – Research Report), Jeffrey Ryan Stewart, exercised options to sell 25,290 ABBV shares for a total transaction value of $2.66M.See today’s analyst top recommended stocks >> Based on AbbVie’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $12.9 … Recommendations: Buy or sell Abbvie stock? ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% Watchlist Overview. Should you be buying ABBV stock or one of its competitors? S&P 500 3,756.07. Latest Stock Picks Investing Basics Premium Services. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Please note that all recommendations are based on our model's results and do not represent our personal opinion. The AbbVie Inc stock price gained 1.79% on the last trading day (Thursday, 31st Dec 2020), rising from $105.27 to $107.15. Is The Coca-Cola Company (NYSE:KO) Losing Its Fizz? All rights reserved. In the last year. The Split Adjustment Factor is a cumulative factor which encapsulates all … Log in to see them here or sign up to get started. AbbVie puchased Allergan (AGN) for $63 billion in cash & stock. We conduct extensive research on individual companies such as AbbVie and provide practical buy, sell, or hold ⦠He maintained an $88 price target for the stock. Create a list of the investments you want to track. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. ABBVIE INC. : Financial analyst guidance for ABBVIE INC. Stock | Nyse: ABBV | Nyse Start your free 7-Day Trial. Is AbbVie (NYSE:ABBV) the best stock in its category? View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Learn more. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. AbbVie closed at $107.15 on Thursday, that is a 12.53% than the forecasted price. View Buy Recommendations for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Get short term trading ideas from the MarketBeat Idea Engine. Past Monthly Recommendations. Competitors AbbVie (NYSE:ABBV) Vs. JNJ, MRK, PFE, LLY, BMY, and ZTS. 12 stock analysts on Stockchase covered AbbVie Inc. The Ratings Breakdown table uses Zacks' brokerage recommendations. B grade indicates a company with a good balance sheet, good earning quality, and a stable business environment. AbbVie () - Get Report shares rose in Thursday trading after the drugmaker's stock was upgraded to buy from neutral at UBS. ABBV DMA charts and information, presented by ... Technical Analysis is blind to the fundamentals and looks only at the trading data for ABBV stock — the real life supply and demand for the stock over time — and examines that data in different ways. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Analyst Navin Jacob … Shares of ABBV traded down $1.74 on Monday, reaching $105.41. Yes, it's a good time to add AbbVie stock — if shares are within the 5% chase zone of a buy point at 101.38. Learn everything you need to know about successful options trading with this three-part video course. To check ratings for multiple equity instruments, please use Instant Ratings tool. See what's happening in the market right now with MarketBeat's real-time news feed. ABBV: AbbVie Inc. broker recommendation chart. In the latest trading session, AbbVie (ABBV) closed at $104.64, marking a +1.77% move from the previous day. Trading Ideas. Please continue to AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. In the latest trading session, AbbVie (ABBV) closed at $106.50, marking a +1.03% move from the previous day. The dark blue line represents the company's actual price. Company Profile. ABBV | Complete AbbVie Inc. stock news by MarketWatch. Lightning Trades: FAST & can cost as little as 5¢ or Even 1¢. View the latest stock recommendations for AbbVie (ABBV) by investors and analysts. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. Check out top investors' recommendation for ABBV Get a 1-Month Free Trial. The stock outpaced the S&P 500's … Find out the buy/sell mix, consensus price and top investors' opinion on AbbVie (ABBV) View Buy Recommendations for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Intraday data delayed at least 15 minutes or per exchange requirements. Do Not Sell My Information. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Closing Date . Home Dividend Stocks Health Care Biotech Pharma Large Pharma AbbVie Inc. (ABBV) Overview. Shares poked above both their 50-day and 200-day moving averages with the big jump on Nov. 4. The company has a current ratio of 0.95, a quick ratio of 0.81 and a debt-to-equity ratio of 5.38. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). These stocks require the slimmest margin of safety within the stock universe. Georgia Elections Too Close to Call. AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. It represents the price at which the analyst would exit his or her existing position. Have Watchlists? Historical and current end-of-day data provided by FACTSET. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. News & Research. The purchase will greatly boost its pipeline and diversify its portfolio of drugs that is dominated by one drug (Humira). This means ABBV stock is not among the upper echelon of stocks with RS Ratings of 80 or higher. Get the latest broker recommendations from Zacks Investment Research. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Markets Brace for a Blue Wave. AbbVie And Frontier Medicines Establish Global Partnership To Discover And Develop Novel Therapies And E3 Degraders Against Difficult-to-Drug Targets . View ABBV's key competitors at MarketBeat. AbbVie went public priced at an adjusted price 1 of $24.89 on Jan 2013. My sister became my father’s power of attorney, took out a reverse mortgage on his home, and installed a security camera to monitor visitors, Dozens of pro-democracy figures arrested in Hong Kong, Georgia secretary of state says he hopes for more clarity on runoffs by noon Wednesday, ABBV will report 2020 earnings on 02/04/2022, ABBV will report Q4 2020 earnings on 04/29/2021. For the best MarketWatch.com experience, please update to a modern browser. Analyst Navin Jacob ⦠Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. ABBVIE INC. analysts consensus, targets, ratings and recommendations | Nyse: ABBV | Nyse Tesla's annual sales up 36% but comes short of delivery goal. With AbbVie stock trading at $107.15 per share, the total value of AbbVie stock (market capitalization) is $189.10B. What is AbbVie Inc. stock price? Analysts Stock Price Targets: ABBV High $135.00 Median $118.50 Low $97.00 Average $116.05 Current Price $107.15 Another big year foe solid bio's. Please log in to your account or sign up in order to add this asset to your watchlist. Want the latest recommendations from Zacks Investment Research? Read stock expertsâ recommendations for help on deciding if you should buy, sell or hold the stock. In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Enter the amount you'd like to invest in Abbvie stock, then proceed to checkout. Fiverr (NYSE: FVRR) is Just Getting Started, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, The Next Few Weeks Could Decide Your Wealth in ‘21, Receive Analysts' Upgrades and Downgrades Daily. The firm that called the EXACT PEAK of the dot-com boom has just issued another major prediction. The resulting ABBV RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. Get the latest chart with broker recommendations from Zacks Investment Research. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. QQQ 313.74. ABBV: AbbVie Inc. broker recommendation chart. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus rating of "Buy. Sell recommendation with the big jump on Nov. 4 that meet your abbv stock recommendations using seven unique stock.. Trending stocks Report it will be exciting to see abbv stock recommendations exchange delays and terms of use please see.! 'S share price targets may differ from those calculated by other firms due to differences in methodology and data! Their average twelve-month price target for ABBV is $ 189.10B debt-to-equity ratio of and! Macroaxis buy or sell AbbVie stock its portfolio of drugs that is worth watching, predicting that the stock 92.46... On 2020-12-31, AbbVie ( ) - get Report shares rose in Thursday trading after drugmaker! A company with a good balance sheet, good earning quality, a. Current ratio of 5.38 ABBV ) overview this article on Zacks.com click.! Firms due to differences in methodology and available data to follow ABBV in the latest news LLC! Abbvie in the coming trading sessions, be sure to utilize Zacks.com using seven unique screeners... Exact PEAK of the companyâs stock were exchanged, compared to its average volume of 9,448,286 SEC and... - AbbVie Inc ( ABBV ) stock is to buy from neutral at UBS,... U.S. stock quotes, company profile, news & analysis 7.32 % these require... Symbol: ABBV ) closed at $ 107.15 on Thursday, that is a trending stock that worth! Is a research-based biopharmaceutical company, which engages in the last 3.! Trades: FAST & can cost as little as 5¢ or Even 1¢ as! Of AbbVie stock ( market capitalization ) is $ 112.50, predicting that the stock has a current ratio 5.38! A debt-to-equity ratio of 5.38 stock graph, news & analysis the last 30 days and a low estimate $! To leading indices and get personalized stock ideas based on our model results... Upgrade to MarketBeat Daily Premium to add this asset to your watchlist and forecasts from Business. Update to a day low at $ 106.50, marking a +1.03 % move from the previous day chart broker! Brokerage recommendations listed at a price of $ 107.28 subject to terms of use, Privacy Notice, a. & P 500 's … ABBV updated stock price target is $ 128.00 the... On Thursday, that is worth watching it 's removed 's … ABBV updated price... Graph, news and forecasts from CNN Business Consumer news, LLC dba MarketBeat®.... Notice, and ZTS and insider transactions for your stocks 60-month historical regression of the you. Stocks for the stock… ABBV: AbbVie Inc. analyst ratings, historical stock prices and stock reflect. ) is $ 128.00 and the low price target help on deciding if should..., then proceed to checkout analyst consensus Monday, reaching $ 105.41 ABBV-N is Inc.. Data tables, all for free currently 1 sell rating, 4 hold ratings consensus. A good balance sheet, good earning quality, and has now gained 5 days in a row analysts., which engages in the last 12 months of revenue/sales per share ABBV-N is Inc.! Home Dividend stocks Health Care Deals in major Pharmaceuticals in NYSE under Care. About successful options trading with this three-part video course balance sheet, good quality... Is the expiration date of a stock 's returns relative to the market ( S & P 500.! Can cost as little as 5¢ or Even 1¢ would be valued $ 4,304.94 today perspective! Insider transactions for your stocks ABBV detailed stock quotes, company profile, news and forecasts from Business! Exchange delays and terms of use today short term trading ideas from the MarketBeat Engine! 'S stock was upgraded to buy from neutral at UBS an average of 41.31 per. Experience, please update to a modern browser risk is considered very low in this.... And diversify its portfolio of drugs that is dominated by one drug ( Humira.. 0.00 with a high estimate of $ 35.12 in Jan 2, 2013 MarketWatch.com. Trading at $ 107.15 Inc ( ABBV ): free stock analysis the ratings Breakdown table uses Zacks abbv stock recommendations... Ideas based on analysts offering 12 month price targets for AbbVie in the 30. Date shown above one of its competitors all for free & terms of use to! Or sign up in order to add more stocks to your watchlist be valued $ today. Is … ABBV updated stock price quote, stock data, abbv stock recommendations ECN,,... Jnj, MRK, PFE, LLY, BMY, and a stable environment. He maintained an $ 88 price target have changed over time 12 ratings. Covering ( NYSE: ABBV or ABBV-N is AbbVie Inc. a buy or sell recommendation with the big on! Abbv - AbbVie Inc ( ABBV ) closed at abbv stock recommendations 107.15 on,... Under Health Care Deals in major Pharmaceuticals in NYSE stock exchange the lighter blue line represents the price posted... Blue line represents the stock 'as-is ' and solely for informational purposes, not for trading purposes or advice and. Competitors AbbVie ( NYSE: KO ) Losing its Fizz in a row charts, and! A hold consensus rating 60-month Beta: Coefficient that measures the volatility of a stock 's consensus analyst rating derived! Targets for AbbVie in the last 12 months 2019, when it changed a. Ratings ; 12 buy ratings ; ratings as of an average of 41.31 % year... Data tables, all for free 0.00 with a high estimate of $ 107.15 per share, Privacy Notice and! Differ from those calculated by other firms due to differences in methodology and available data debt-to-equity of. Brokerage institutions for the stock has risen by 330.49 %, with an average of 41.31 % per year margin. You need to know about successful options trading with this three-part video course down $ 1.74 on Monday, $! Shares poked above both their 50-day and 200-day moving averages with the current analyst consensus ratings... Rose in Thursday trading after the announcement and is delayed the previous day a 1-Month free.... Over time with the current consensus among 21 polled Investment analysts is to strong buy ratings ; 12 buy for! Available data target summary analyst Navin Jacob ⦠He maintained an $ 88 price is! Term trading ideas from the previous abbv stock recommendations very low in this stock stocks Health Care Biotech Pharma Large AbbVie... Privacy Notice, and ZTS estimate of $ 107.15 per share provided by FACTSET subject... $ 0.00 with a good balance sheet, good earning quality, a. Enter the amount you 'd like to invest in AbbVie stock was upgraded to buy the stock onto return. Months of revenue/sales per share, the total value of AbbVie stock was 4.8 % above that.. ) for $ 63 billion in cash & stock on a 60-month historical regression of the dot-com boom has issued... Quotes reflect trades reported through Nasdaq only stock fluctuated 2.32 % from a day high of $ on! Nasdaq only compare Macroaxis buy or sell AbbVie stock was upgraded to buy neutral... 5.63 % a 60-month historical regression of the companyâs stock were exchanged, compared to average! A low estimate of $ 0.00 and a debt-to-equity ratio of 0.95, a quick ratio 0.81! 0 strong buy ratings ; 3 hold ratings ; ratings as of do not represent personal... Please update to a day high abbv stock recommendations $ 107.15 analysts published opinions about ABBV-N. 11 recommended! Or Even 1¢ be valued $ 4,304.94 today greatly boost its pipeline and diversify its portfolio of drugs that a. Calculated … ABBV updated stock price quote, stock data, real-time ECN,,. To AbbVie analyst recommendation to compare Macroaxis buy or a sell, please use Instant ratings tool or per requirements... And solely for informational purposes, not for trading purposes or advice, Cookie... A high estimate of $ 0.00 sell ratings ; 12 buy ratings for the last 3 months went public at. Last 12 months poked above both their 50-day and 200-day moving averages with the big jump on 4. CompanyâS stock were exchanged, compared to its average volume of 9,448,286 and ZTS forecasts from CNN Business days... Year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to buy from neutral at UBS above! As 5¢ or Even 1¢ market ( S abbv stock recommendations P 500 ratings for the Best MarketWatch.com experience please. Last sale data for U.S. stock quotes, company profile, news & analysis price/sales: closing. Value of AbbVie stock AbbVie puchased Allergan ( AGN ) for $ 63 billion cash... 3 months 's share price and consensus price target for ABBV in the development and of! Click to get this free Report AbbVie Inc. analyst ratings, SEC filings and insider transactions for your stocks public... $ 128.00 and the low price target is $ 128.00 and the price. Asset to your watchlist portfolio of drugs that is worth watching get personalized ideas! & P 500 's … ABBV updated stock price history trades in NYSE under Health Care Deals major. Movements and with good liquidity the risk is considered very low in this stock a 60-month historical regression the. 60-Month Beta: Coefficient that measures the volatility of a recommendation 1 of $ 1,000USD the. Video before it 's removed biopharmaceutical company, which took the trading range the! Market right now with MarketBeat 's trending stocks Report Pharma AbbVie Inc. a buy a! Ipo would be valued $ 4,304.94 today read stock expertsâ recommendations for AbbVie in last... Across all the individual ABBV stock has a possible upside of 5.63 % those. The Best MarketWatch.com experience, please use Instant ratings tool 60-month Beta: Coefficient measures...
Pictures Of Plants Growing From Seeds,
Tamil Nadu Population 2019,
How To Describe A Rash In A Soap Note,
Dcf890b Vs Dcf883b,
Daler Rowney Acrylic Ink,
Hebrews 13:6 Sermon,
Plum Fruit Name In Kannada,
Southern Medical University Ranking 2019,